← All stocks

OptimizeRx Corp

OPRX Scheduled selling only
CIK 0001448431 #4101 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$49.13K
$0.00 on a plan · $49.13K straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
−$49.13K
$0.00 against sales at will

By person

14 insiders · 2 transactions
4.9×

Stephen Silvestro holds only 4.9 times base salary in stock. $2.48M of shares against $500.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Silvestro last reported holding, valued at $13.51, the price Common Stock was last bought or sold at on the open market here, on 19 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Silvestro Stephen L
Chief Executive Officer
$30.38K (1) scheduled
−$30.38K
183,551
0.9745%
$2.48M
Stelmakh Edward
Chief Finance & Strat Officer
$18.75K (1) scheduled
−$18.75K
121,791
0.6466%
$1.65M
+265.0%
FEBBO WILLIAM J
CEO
600,852
3.19%
$8.12M
+3.4%
Lang James Paul
Director
433,837
2.30%
$5.86M
+537.6%
Vos Ellen O'Connor
Director
107,159
0.5689%
$1.45M
+70.7%
D'Silva Andrew J.
Chief Business Officer
99,660
0.5291%
$1.35M
+168.6%
WASSON GREGORY D
Director
91,700
0.4868%
$1.24M
+93.8%
Odence-Ford Marion
Chief Legal & Admin Officer
90,407
0.4800%
$1.22M
Spangler Patrick D
Director
78,732
0.4180%
$1.06M
+73.2%
Greco Theresa
Chief Commercial Officer
71,075
0.3773%
$960.22K
+91.9%
Besch Doug
Chief Product & Tech Officer
66,876
0.3550%
$903.49K
+752.1%
KLEMA CATHY
Director
56,137
0.2980%
$758.41K
+745.1%
Presti Mariyamma Varghese
Director
30,318
0.1610%
$409.60K
Merrell Brendan W.
CHIEF OPERATING OFFICER
25,187
0.1337%
$340.28K
Insider
Date
Role
Action
Shares
Price
Amount
Stelmakh Edward
19 Dec 2025
Chief Finance & Strat Officer
Sold after exercise
1,388
$13.51
$18.75K
Silvestro Stephen L
3 Oct 2025
Chief Executive Officer
Sold after exercise
1,620
$18.75
$30.38K

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 559,758
History held since 14 Nov 2016